Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2.3

Margin Of Safety %

22

Put/Call OI Ratio

0.64

EPS Next Q Diff

0.36

EPS Last/This Y

9.72

EPS This/Next Y

1.48

Price

238.87

Target Price

266.44

Analyst Recom

1.76

Performance Q

10.09

Relative Volume

1.14

Beta

1.06

Ticker: LH




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19LH226.990.840.524948
2024-12-20LH228.660.831.035069
2024-12-23LH227.90.840.033170
2024-12-24LH229.490.720.543491
2024-12-26LH231.10.728.003530
2024-12-27LH230.620.930.314056
2024-12-30LH228.820.930.304082
2024-12-31LH229.290.930.314093
2025-01-02LH228.190.930.544097
2025-01-03LH229.20.920.084121
2025-01-06LH229.970.900.124179
2025-01-07LH235.270.890.114209
2025-01-08LH234.330.890.014210
2025-01-09LH234.310.890.014210
2025-01-10LH2320.700.504831
2025-01-13LH234.440.7115.114814
2025-01-14LH234.460.723.044873
2025-01-15LH237.170.670.304868
2025-01-16LH238.670.670.244866
2025-01-17LH238.870.640.005375
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19LH227.052.9939.114.52
2024-12-20LH228.452.9943.414.52
2024-12-23LH227.842.9930.314.52
2024-12-24LH229.492.9944.414.52
2024-12-26LH231.062.9943.914.52
2024-12-27LH230.712.9932.814.52
2024-12-30LH228.902.9925.914.52
2024-12-31LH229.072.9936.014.52
2025-01-02LH228.202.9928.314.52
2025-01-03LH229.152.9940.414.52
2025-01-06LH229.902.9939.114.52
2025-01-07LH235.162.9965.114.52
2025-01-08LH234.312.9930.314.52
2025-01-09LH234.312.9934.814.52
2025-01-10LH232.002.9921.614.52
2025-01-13LH234.252.9947.714.52
2025-01-14LH234.542.9937.314.52
2025-01-15LH237.302.9950.714.52
2025-01-16LH238.802.9943.214.52
2025-01-17LH238.872.8935.314.52
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19LH-16.12-1.592.37
2024-12-20LH-16.12-1.592.37
2024-12-23LH-16.03-1.592.37
2024-12-24LH-16.03-1.592.37
2024-12-26LH-16.03-1.592.36
2024-12-27LH-16.12-1.592.36
2024-12-30LH-16.16-1.602.36
2024-12-31LH-16.16-1.602.36
2025-01-02LH-16.10-1.602.36
2025-01-03LH-16.12-1.602.36
2025-01-06LH-16.07-1.642.36
2025-01-07LH-16.07-1.642.36
2025-01-08LH-16.37-1.642.36
2025-01-09LH-16.37-1.642.36
2025-01-10LH-16.37-1.642.36
2025-01-13LH-16.37-1.022.30
2025-01-14LH-16.37-1.022.30
2025-01-15LH-16.37-1.022.30
2025-01-16LH-16.37-1.022.30
2025-01-17LH-16.37-1.022.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

3.5

Avg. EPS Est. Current Quarter

3.4

Avg. EPS Est. Next Quarter

3.86

Insider Transactions

-16.37

Institutional Transactions

-1.02

Beta

1.06

Average Sales Estimate Current Quarter

3309

Average Sales Estimate Next Quarter

3410

Fair Value

290.51

Quality Score

59

Growth Score

77

Sentiment Score

81

Actual DrawDown %

12.3

Max Drawdown 5-Year %

-46.6

Target Price

266.44

P/E

46.19

Forward P/E

14.88

PEG

5.49

P/S

1.57

P/B

2.44

P/Free Cash Flow

23.66

EPS

5.16

Average EPS Est. Cur. Y​

14.52

EPS Next Y. (Est.)

16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.43

Relative Volume

1.14

Return on Equity vs Sector %

-13.7

Return on Equity vs Industry %

-5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

935.3
Labcorp Holdings Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 67000
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
stock quote shares LH – Laboratory Corporation of America Holdings Stock Price stock today
news today LH – Laboratory Corporation of America Holdings stock forecast ,stock prediction 2023 2024 2025
marketwatch LH – Laboratory Corporation of America Holdings yahoo finance google finance
stock history LH – Laboratory Corporation of America Holdings invest stock market
stock prices LH premarket after hours
ticker LH fair value insiders trading